chr9-137716851-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024757.5(EHMT1):c.311C>T(p.Ala104Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,613,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_024757.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EHMT1 | NM_024757.5 | c.311C>T | p.Ala104Val | missense_variant | 3/27 | ENST00000460843.6 | NP_079033.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EHMT1 | ENST00000460843.6 | c.311C>T | p.Ala104Val | missense_variant | 3/27 | 5 | NM_024757.5 | ENSP00000417980.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152120Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000143 AC: 36AN: 250944Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135780
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461010Hom.: 0 Cov.: 31 AF XY: 0.000132 AC XY: 96AN XY: 726768
GnomAD4 genome AF: 0.000263 AC: 40AN: 152238Hom.: 0 Cov.: 31 AF XY: 0.000228 AC XY: 17AN XY: 74428
ClinVar
Submissions by phenotype
Kleefstra syndrome 1 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 10, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2019 | - - |
EHMT1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 16, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at